GlassScriptPhysician profile
Balu B Shetty
NPI 1033104948
$2,606.00
in general payments reported to CMS, 2019-2025
18 companies · $63.12 in 2025
The $63.12 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $171 · 2020: $67.81 · 2021: $211 · 2022: $1,158 · 2023: $880 · 2024: $54.19 · 2025: $63.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $754 · Gift: $243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $754.39 |
| Gift | $243.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braintree Laboratories, INC. | $459.71 | 2020-2023 | Sutab, Suflave |
| Abbvie INC. | $429.76 | 2021-2024 | Skyrizi, Viberzi, Linzess |
| Takeda Pharmaceuticals U.S.A., INC. | $421.21 | 2022-2023 | Entyvio |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $259.13 | 2019-2024 | Xifaxan |
| E.R. Squibb & Sons, L.L.C. | $160.50 | 2022 | |
| Gilead Sciences, INC. | $141.11 | 2023 | Epclusa |
| Genzyme Corporation | $129.99 | 2022-2024 | |
| Regeneron Healthcare Solutions, INC. | $127.66 | 2022-2023 | Dupixent |
| Ardelyx, INC. | $107.51 | 2022 | |
| Janssen Biotech, INC. | $102.37 | 2023-2025 | Tremfya, Stelara |
| Nestle Healthcare Nutrition INC. | $49.65 | 2023 | |
| Ironwood Pharmaceuticals, INC | $42.11 | 2023 | Linzess |
| Celgene Corporation | $41.84 | 2021-2023 | Zeposia |
| Digestive Care, INC. | $38.54 | 2023 | Pertzye |
| Ferring Pharmaceuticals INC. | $33.52 | 2020-2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conmed Corporation | $24.88 | 2021 | |
| Amgen INC. | $20.14 | 2023 | Avsola, Amjevita |
| Redhill Biopharma INC. | $16.37 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Balu Shetty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.